BioVie
$9.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.17 (-1.80%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell BioVie and other stocks, options, and ETFs commission-free!
About BIVI
BioVie Inc. Class A Common Stock, also called BioVie, is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. Read More It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA. The listed name for BIVI is BioVie Inc. Class A Common Stock.
Employees
—
Headquarters
Santa Monica, California
Founded
2013
Market Cap
63.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
53.06K
High Today
$9.25
Low Today
$9.00
Open Price
$9.22
Volume
8.87K
52 Week High
$34.54
52 Week Low
$2.20
Collections
BIVI Earnings
Q3 2020
Q4 2020
Q1 2021
Estimated
— per share
Actual
—